Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Guideline
. 2015 Feb;42(2):328-54.
doi: 10.1007/s00259-014-2961-x. Epub 2014 Dec 2.

FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0

Ronald Boellaard  1 , Roberto Delgado-Bolton, Wim J G Oyen, Francesco Giammarile, Klaus Tatsch, Wolfgang Eschner, Fred J Verzijlbergen, Sally F Barrington, Lucy C Pike, Wolfgang A Weber, Sigrid Stroobants, Dominique Delbeke, Kevin J Donohoe, Scott Holbrook, Michael M Graham, Giorgio Testanera, Otto S Hoekstra, Josee Zijlstra, Eric Visser, Corneline J Hoekstra, Jan Pruim, Antoon Willemsen, Bertjan Arends, Jörg Kotzerke, Andreas Bockisch, Thomas Beyer, Arturo Chiti, Bernd J Krause; European Association of Nuclear Medicine (EANM)
Affiliations
Guideline

FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0

Ronald Boellaard et al. Eur J Nucl Med Mol Imaging. 2015 Feb.

Abstract

The purpose of these guidelines is to assist physicians in recommending, performing, interpreting and reporting the results of FDG PET/CT for oncological imaging of adult patients. PET is a quantitative imaging technique and therefore requires a common quality control (QC)/quality assurance (QA) procedure to maintain the accuracy and precision of quantitation. Repeatability and reproducibility are two essential requirements for any quantitative measurement and/or imaging biomarker. Repeatability relates to the uncertainty in obtaining the same result in the same patient when he or she is examined more than once on the same system. However, imaging biomarkers should also have adequate reproducibility, i.e. the ability to yield the same result in the same patient when that patient is examined on different systems and at different imaging sites. Adequate repeatability and reproducibility are essential for the clinical management of patients and the use of FDG PET/CT within multicentre trials. A common standardised imaging procedure will help promote the appropriate use of FDG PET/CT imaging and increase the value of publications and, therefore, their contribution to evidence-based medicine. Moreover, consistency in numerical values between platforms and institutes that acquire the data will potentially enhance the role of semiquantitative and quantitative image interpretation. Precision and accuracy are additionally important as FDG PET/CT is used to evaluate tumour response as well as for diagnosis, prognosis and staging. Therefore both the previous and these new guidelines specifically aim to achieve standardised uptake value harmonisation in multicentre settings.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Avril NE, Weber WA. Monitoring response to treatment in patients utilizing PET. Radiol Clin North Am. 2005;43(1):189–204. doi: 10.1016/j.rcl.2004.09.006. - DOI - PubMed
    1. Bastiaannet E, Groen H, Jager PL, et al. The value of FDG-PET in the detection, grading and response to therapy of soft tissue and bone sarcomas; a systematic review and meta-analysis. Cancer Treat Rev. 2004;30(1):83–101. doi: 10.1016/j.ctrv.2003.07.004. - DOI - PubMed
    1. Borst GR, Belderbos JSA, Boellaard R, et al. Standardised FDG uptake: a prognostic factor for inoperable non-small cell lung cancer. Eur J Cancer. 2005;41(11):1533–1541. doi: 10.1016/j.ejca.2005.03.026. - DOI - PubMed
    1. Erdi YE. The use of PET for radiotherapy. Curr Med Imaging Rev. 2007;3(1):3–16.
    1. Geus-Oei LF, van der Heijden HF, Corstens FH, Oyen WJ. Predictive and prognostic value of FDG-PET in nonsmall-cell lung cancer: a systematic review. Cancer. 2007;110(8):1654–1664. doi: 10.1002/cncr.22979. - DOI - PubMed

Publication types

MeSH terms

Substances